Ghost Tree Capital’s Epizyme, Inc EPZM Stock Holding History

Ghost Tree Capital’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-132,000	Closed	-$1.36M	–	65
2019 Q3	$1.36M	Sell	132,000 -333,000	-72%	-$4.2M	0.35%	42
2019 Q2	$5.84M	Sell	465,000 -35,000	-7%	-$450K	1.21%	26
2019 Q1	$6.2M	Buy	+500,000	New	+$5.59M	1.62%	25
2017 Q3	–	Sell	-150,000	Closed	-$2.27M	–	82
2017 Q2	$2.27M	Sell	150,000 -450,000	-75%	-$6.8M	0.47%	60
2017 Q1	$10.3M	Buy	600,000 +125,000	+26%	+$1.66M	1.92%	15
2016 Q4	$5.75M	Buy	+475,000	New	+$4.96M	1.38%	34
2015 Q4	–	Sell	-150,000	Closed	-$1.93M	–	74
2015 Q3	$1.93M	Sell	150,000 -100,000	-40%	-$2.02M	0.87%	47
2015 Q2	$6M	Buy	250,000 +135,000	+117%	+$2.6M	1.94%	19
2015 Q1	$2.16M	Buy	+115,000	New	+$2.37M	0.78%	53
2014 Q2	–	Sell	-45,000	Closed	-$1.02M	–	79
2014 Q1	$1.02M	Buy	+45,000	New	+$1.36M	0.61%	48

Other funds holding EPZM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ghost Tree Capital's EPZM Position: Q4 2019 in Review

Ghost Tree Capital sold out of Epizyme, Inc (EPZM) in Q4 2019, closing a stake of 132,000 shares — an estimated $1.36M sold.

Ghost Tree Capital first reported a position in EPZM in Q1 2014 and held it in 10 quarters. The position peaked at $10.3M in Q1 2017. 136 funds tracked by Wall St. Rank hold EPZM as of Q4 2019.

Ghost Tree Capital reported no remaining Epizyme, Inc position as of Q4 2019 after selling out during the quarter.
Ghost Tree Capital sold 132,000 Epizyme, Inc shares in Q4 2019, an estimated $1.36M.
Ghost Tree Capital first reported a position in Epizyme, Inc in Q1 2014 and held it in 10 quarters.
Ghost Tree Capital's Epizyme, Inc position peaked at $10.3M in Q1 2017.
136 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2019.

Based on Ghost Tree Capital's 13F filing for Q4 2019, filed 14 Feb 2020.